US biotech firms would need export licenses to share DNA designs with rival nations

What does this do?

S 3452 would require American companies and researchers to obtain a government export license before sharing digital files of synthetic DNA or RNA sequences with entities in countries designated as national security threats. The Department of Commerce would have one year to build and launch the licensing system. Information already considered publicly available would be exempt from the requirement.

Who does it affect?

US biotechnology companies, university research labs, and scientists who share or sell synthetic biology data with partners in flagged countries would need to apply for licenses before sending that information. Foreign companies and research institutions in countries of concern would face restricted access to US-designed genetic sequence files.

Why does it matter?

Congress has expressed concern that custom DNA and RNA sequence designs sent to countries like China could reach foreign military or intelligence services. Organizations currently sharing synthetic biology data internationally would face a new approval process that did not previously exist for these digital files.

Where does it stand?